MedPath

A study to evaluate the efficacy of lignocaine (local anaesthetic drug)and ketamine for preventing pain on injection of rocuronium and propofol.

Not Applicable
Conditions
Health Condition 1: R69- Illness, unspecified
Registration Number
CTRI/2022/06/043409
Lead Sponsor
DR SWETA SALGAONKAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. PATIENT POSTED FOR ELECTIVE SURGERY UNDER GENERAL ANAESTHESIA WITH ENDOTRACHEAL INTUBATION AND POSITIVE PRESSURE VENTILATION.

2. ASA-I AND ASA-II PATIENT

Exclusion Criteria

1. ASA III,IV Patients

2. Patients with known allergy to propofol, rocuronium, lignocaine

3. Patients with neuromuscular disorder or cognitive disorder, high intracranial pressure; uncontrolled hypertension; heart failure; ischaemic heart disease, diabetes mellitus; use of any analgesic drug within the last 24 h; and pregnancy.

4 patients with poor venous access, difficult airway

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain on injection of propofol and rocuroniumTimepoint: 20 sec after injection of propofol, 10 sec after injection of rocuronium
Secondary Outcome Measures
NameTimeMethod
Pulse rate, blood pressure, respiratory rate, spo2, etco2Timepoint: 2min, 5min, 10min
© Copyright 2025. All Rights Reserved by MedPath